60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) has a higher price-to-earnings ratio of 1.54x compared to its average ratio, The 36-month beta value for SXTP is at 4.65. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for SXTP is 1.64M, and currently, shorts hold a 1.91% of that float. The average trading volume for SXTP on October 23, 2024 was 434.86K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SXTP) stock’s latest price update
The stock price of 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) has dropped by -8.41 compared to previous close of 1.07. Despite this, the company has seen a gain of 3.16% in its stock price over the last five trading days. globenewswire.com reported 2024-10-03 that Highlights include increased ARAKODA® (tafenoquine) brand awareness and utilization through virtual sales outreach using digital behavioral analytics and a co-pay program to assist consumers with out-of-pocket costs. ARAKODA is the only new antimalarial in over a decade and is differentiated by a broad efficacy against all malaria stages, a convenient weekly dosing schedule, and a well-established safety profile.
SXTP’s Market Performance
60 Degrees Pharmaceuticals Inc (SXTP) has seen a 3.16% rise in stock performance for the week, with a -28.36% decline in the past month and a -53.78% plunge in the past quarter. The volatility ratio for the week is 17.51%, and the volatility levels for the past 30 days are at 10.05% for SXTP. The simple moving average for the past 20 days is -10.55% for SXTP’s stock, with a -68.59% simple moving average for the past 200 days.
SXTP Trading at -26.16% from the 50-Day Moving Average
After a stumble in the market that brought SXTP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.66% of loss for the given period.
Volatility was left at 10.05%, however, over the last 30 days, the volatility rate increased by 17.51%, as shares sank -27.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.51% lower at present.
During the last 5 trading sessions, SXTP rose by +3.16%, which changed the moving average for the period of 200-days by -92.64% in comparison to the 20-day moving average, which settled at $1.0956. In addition, 60 Degrees Pharmaceuticals Inc saw -91.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SXTP starting from XU CHERYL, who purchase 5,000 shares at the price of $1.70 back on Aug 27 ’24. After this action, XU CHERYL now owns 41,078 shares of 60 Degrees Pharmaceuticals Inc, valued at $8,500 using the latest closing price.
DOW GEOFFREY S, the President and CEO of 60 Degrees Pharmaceuticals Inc, purchase 25,974 shares at $0.38 during a trade that took place back on Jan 31 ’24, which means that DOW GEOFFREY S is holding 703,599 shares at $9,740 based on the most recent closing price.
Stock Fundamentals for SXTP
Current profitability levels for the company are sitting at:
- -24.44 for the present operating margin
- -0.02 for the gross margin
The net margin for 60 Degrees Pharmaceuticals Inc stands at -4.14. The total capital return value is set at -2.88.
Based on 60 Degrees Pharmaceuticals Inc (SXTP), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -39.03. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -176.69.
Currently, EBITDA for the company is -5.05 million with net debt to EBITDA at 0.5. When we switch over and look at the enterprise to sales, we see a ratio of 1.11. The receivables turnover for the company is 1.23for trailing twelve months and the total asset turnover is 0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.08.
Conclusion
In conclusion, 60 Degrees Pharmaceuticals Inc (SXTP) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
